Romania's Antitrust Watchdog Fines Boehringer Ingelheim RCV RON128M For Abuse Of Dominant Position
Jan 14, 2025
Romania's Antitrust Watchdog Fines Boehringer Ingelheim RCV RON128M For Abuse Of Dominant Position.
Romania's Competition Council has fined Boehringer Ingelheim RCV GmbH & Co KG (Austria) a total RON128.47 million (EUR25.81 million) for abusing its dominant position in Romania’s market for medicines treating chronic obstructive pulmonary disease (COPD).
[Read the article in Ziarul Financiar]